Analkreft handlingsprogram

Felles 001 Deksrazoksan, Savene

Felles 003, 004, 084 Bevacizumab

Felles 005 FLOX/bevacizumab

Felles 006 FLIRI/bevacizumab

Felles 011 Doksorubicin -7

Felles 012, 013 Docetaksel -21

Felles 014 Docetaksel -7, 30 mg/m2

Felles 016 Docetaksel/karboplatin AUC5

Felles 017 Doksorubicin liposomal

Felles 019 FLIRI, fluorouracil/kalsiumfolinat/irinotekan

Felles 020 FLOX, fluorouracil/kalsiumfolinat/oksaliplatin

Felles 021 Irinotekan-21

Felles 022 Karboplatin AUC5/pemetreksed

Felles 023 Paklitaksel -7

Felles 025 Trastuzumab iv 1. kur

Felles 026 Trastuzumab iv 2. kur og senere

Felles 027 Vinorelbin 25 mg/m2, dag 1 og 8

Felles 028, 074, 075, 076 Zoledronsyre

Felles 041 Nivolumab 3mg/kg

Felles 042 EDP, Cisplatin/doksorubicin/etoposid

Felles 046, 047 Fluorouracil/streptozocin

Felles 048, 063 Pembrolizumab iv

Felles 051 Cisplatin/pemetreksed

Felles 053, 054, 139 Nivolumab iv

Felles 056 HIPEC Mitomycin intraperitonealt

Felles 057 HIPEC Karboplatin intraperitonealt

Felles 064, 091 MK3475-158 Pembrolizumab

Felles 069 Cetuksimab -14, 500 mg/m2

Felles 080 Ipilimumab 1 mg/kg / nivolumab 3mg/kg

Felles 082 Docetaksel -14

Felles 089c BMS-986218 40mg / nivolumab 480mg CA022001 part 2C/2D

Felles 092 Atezolizumab/bevacizumab

Felles 131 Gemcitabine/karboplatin AUC5

Felles 133 FOLFOX

Felles 137 CHRO761A12101 Irinotekan ARM C

Felles 138 CHRO761A12101 Tislelizumab ARM B

Felles 146 Durvalumab – 28, pasient over 30 kg

GI 008 FLIRI/cetuksimab 500 mg/m2

GI 009 Irinotekan -14

GI 011 FOLFIRI Fluorouracil/ kalsiumfolinat/irinotekan

GI 012 FOLFIRINOX

GI 013 FOLFOXIRI

GI 016 CAPOX Kapecitabin/oksaliplatin

GI 018 FLV Fluorouracil/kalsiumfolinat

GI 020 FLV ved stråleterapi

GI 021a Gemcitabin/kapecitabin

GI 022abc Gemcitabin

GI 023abc Gemcitabin/paklitakselalbumin -28 -21 -14

GI 024 Panitumumab

GI 029 GEMOX

GI 029ab GEMOX

GI 030 Fluorouracil dag 1-5/karboplatin AUC5

GI 031 Fluorouracil infusor 120 timer/karboplatin AUC5

GI 033 CiFu Cisplatin/fluorouracil d 1-4 anal-spiserør

GI 034 CiFu Cisplatin 75 mg/m2 /fluorouracil infusor 96t

GI 036 Cisplatin/fluorouracil/trastuzumab iv 1. kur

GI 037 Cisplatin/fluorouracil/trastuzumab iv 2 kur +

GI 038 Cisplatin/kapecitabin/trastuzumab iv, 1. kur

GI 039 Cisplatin/kapecitabin/trastuzumab iv 2. kur+

GI 042 Fluorouracil/oksaliplatin/ trastuzumab iv, 1. kur

GI 043 Fluorouracil/oksaliplatin/trastuzumab iv, 2.kur +

GI 044 FLIRI/panitumumab

GI 045 Fluorouracil infusor 96 timer/oksaliplatin

GI 048 CAPOX/trastuzumab iv, 1 kur

GI 049 CAPOX/trastuzumab iv, 2. kur +

GI 050 FLOT Docetaksel/fluorouracil/ kalsiumfolinat/oksaliplatin

GI 054 Karboplatin AUC5/paklitaksel

GI 067ab EP-GI cisplatin/etoposid

GI 068abc EK-GI Etoposid/karboplatin AUC5

GI 070a: Fluorouracil/streptozotocin, induksjonsbehandling

GI 070b/071: Fluorouracil/streptozotocin, vedlikeholdsbehandling

GI 072ab Cisplatin gemcitabin

GI 086 Cetuksimab 500 mg/m2 /irinotekan

GI 087 Cetuksimab/irinotekan - 21, 1 kur

GI 088 Cetuksimab/irinotekan - 21,     2. kur og senere

GI 089 Irinotekan/panitumumab

GI 091 MiCap kapecitabin/mitomycin ved stråleterapi

GI 112 FOLFIRI/Bevacizumab

GI 114 FOLFIRI/cetuksimab 500 mg/m2

GI 116 FOLFOX/panitumumab

GI 129 mFOLFOX6, definitiv Kjemoradioterapi

GI 133 FOLFIRINOX modifisert

GI 153 FLOX, 5-FU/kalsiumfolinat/ oksaliplatin, METIMMOX

GI 154 Nivolumab METIMMOX

GI 155 FOLFIRI/panitumumab             (5-FU/kalsiumfolinat/irinotek)

GI 156, 157 Fluorouracil infusor 96 t/ oksaliplatin/trastuzumab

GI 164 INCMGA 00012 Podium-studie

GI 191 CORINTH Pembrolizumab 200 mg

GI 192ab FOLFOX med trastuzumab

GI 195 Cadd Solis Etoposid/karboplatin AUC5

GI 196ab, 197, 198ab, 199ab CORINTH kjemo

GI 200 CAPOX/bevacizumab -21

GI 201 FLV/bevacizumab -14, 5 mg/kg

GI 202 CiFu Cisplatin 60 mg/m2 /fluorouracil infusor

GI 203 DCF-modifisert/ Cis/Doc/5-FU infusor 48t

GI 204 TACE Doksorubicin Embozene Tandem

GI 211ab SOx Oksaliplatin 100 og 130 mg/m2/S1 -21

GI 212-217 Docetaksel/trastuzumab iv

GI 220 NIPEC-OXA Oksaliplatin 130 mg/m2, intraperitonealt

GI 223 EXCALIBUR Floksuridine

GI 225a EXCALIBUR Heparin uten floksuridine

GI 225b EXCALIBUR Deksametason heparin uten floksuridine

GI 230 PelvEx II CAPOX kapecitabin/oksaliplatin

GI 231 PelvEx II FOLFOX fluorouracil/leukov/oksaliplatin

GI 232 PelvEx II FOLFIRI fluorouracil/leukovon/irinotekan

GI 233 EVIDENT Gemcitabin

GI 234-235 EVIDENT Cetuksimab

GI 236-237 EVIDENT Pertuzumab/trastuzumab iv

GI 239 EVIDENT Metotreksat

GI 243 FOLFOX/bevacizumab

GI 244 CAPOX/Nivolumab

GI 245 FOLFOX/Nivolumab

GI 246, 247 TACE Doksorubicin mikrosfærer LifePearl 75/150 mg

GI 250b METIMMOX-2 Nivolumab

GI 251 FLV/cetuksimab

GI 252 CAPOX/pembrolizumab

GI 253ab FOLFOX/pembrolizumab

GI 258 FLV/panitumumab

GI 266 METIMMOX-2 FLOX

GI 267 KEYMAKER-06B Paklitaksel

GI 268 KEYMAKER-06B Irinotekan

GI 270-271 FLOX/trastuzumab

GI 272 MOUNTAINEER-03 FOLFOX

GI 273ab MOUNTAINEER-03 Trastuzumab

GI 274 MOUNTAINEER-03 Bevacizumab -14

GI 275ab MOUNTAINEER-03 Cetuksimab

GI 281-282 AZUR-2 Dostarlimab

GI 283 AZUR-2 CAPOX Kapecitabin/oksaliplatin

GI 284 AZUR-2 FOLFOX Fluorouracil/oksaliplatin

GI 285/286 Trastuzumab-14 (1. og senere kur)

GI 288 TOMCAT Floksuridine

GI 289a TOMCAT Heparin, uten floksuridine

GI 289b TOMCAT Deksametason/heparin, uten floksuridine

GI 290 Cisplatin/durvalumab/ gemcitabin, pas. over 30 kg

GI 291ab KEYMAKER-06B MK-2870

GI 292 ARTEMIDE-Biliary01 Rilvegostomig/placebo

GI 293ab Tislelizumab

GI 294 KEYMAKER-06D arm 1 Ramucirumab/paklitaksel

GI 295ab KEYMAKER-06D arm 2 MK-2870/paklitaksel

GI 296 KEYMAKER-06C arm 1 CAPOX/pembrolizumab

GI 297 KEYMAKER-06C arm 1 FOLFOX/pembrolizumab

GI 298 KEYMAKER-06C arm 2 Kapecitabin/MK-2870/pembro

GI 299 KEYMAKER-06C arm 2 FLV/MK-2870/pembro

GI 300 FLOX/Nivolumab

GI 301-303 CRUKD/24/002 Ginisortamab/gemcitabin/paklitakselalbumin

GI 304 Durvalumab/tremelimumab, pasient over 30 kg

GI 305 CiFu-tislelizumab infusor 80/4000 120 timer

GI 306 CAPOX/tislelizumab

GI 307 Cetuksimab 1. kur

GI 308 Cetuksimab 2. kur og senere

GI 309 OPTIMISE, FOLFOXIRI

GI 310 OPTIMISE, 5-FU monoterapi

GI 311abc PSEUDOVAX

GI 312abcd EMBOLD GSK5764227

GI 313 DESTINY-G M1  Fluorour/pembro/trastuz.derukstekan

GI 314 DESTINY-G M1 Kapecit/pembro/trastuz.derukstekan

GI 315ab DESTINY-G M2 Cispl/fluorour/pembro/trastuzumab

GI 316ab DESTINY-G M2 Fluorour/oksali/pembro/trastuzumab

GI 317ab DESTINY-G M2 Cispl/kapecit/pembro/trastuzumab

GI 318ab DESTINY-G M2 Kapecit/oksali/pembro/trastuzumab

GI 319 DESTINY-G E1 Fluorour/trastuzumabderukstekan

GI 320 DESTINY-G E1 Kapecitabin/tratuzumabderukstekan

GI 321ab DESTINY-G E2 Cisplatin/fluorouracil/trastuzumab

GI 322ab DESTINY-G E2 Fluorouracil/oksaliplatin/trastuzumab

GI 323ab DESTINY-G E2 Cisplatin/kapecitabin/trastuzumab

GI 324ab DESTINY-G E2 Kapecitabin/oksaliplatin/trastuzumab

GI 325 FOLFOX/ cetuksimab/enkorafenib

GI 326 KEYMAKER-06E Pembrolizumab-21

GI 327abc KEYMAKER-06E Ifinatamabderuksikan/pembro

GI 328 KEYMAKER-06E FOLFOX -14

GI 329 KEYMAKER-06E FLV-14

GI 330 KEYMAKER-06E Oksaliplatin/fluorouracil-14

GI 331a: Streptozocin, induksjonsbehandling

GI 331b: Streptozocin, vedlikeholdsbehandling

GI 332 SIRI Irinotekan/S1 -21

GI 333 Bevacizumab/S1 -21

GI 336 Studie DSEE-CRC FLOX

GI 337 Studie DSEE-CRC FLIRI

GI 338 Studie DSEE-CRC FLV

GI 339 Studie DSEE-CRC FLOT

GI 340 Studie DSEE-CRC Bevacizumab 5mg/kg

GI 341 Studie DSEE-CRC Panitumumab

GI 342 Studie DSEE-CRC Cetuksimab 500 mg/m2

GI 343 Studie DSEE-CRC Cetuksimab, 1 kur

GI 344 Studie DSEE-CRC Cetuksimab, 2. kur og senere

GI 345 Studie DSEE-CRC Oksaliplatin 130 mg/m2

GI 346-347 Studie DSEE-CRC Docetaksel

GI 348-349 Studie DSEE-CRC Trastuzumab iv

GI 350 Studie DSEE-CRC Gemcitabin

GI 351 Studie DSEE-CRC Metotreksat

GI 352 Studie DSEE-CRC Epirubicin 40 mg

GI 353 Studie DSEE-CRC Irinotekan

GI 354 Studie DSEE-CRC Paklitaksel

GI 355 Studie IDeate-Esophageal01 Ifinatamabderukstekan

GI 359 FOLFIRI-cetuksimab/enkorafenib, fluoro/irino/kalsiumfolinat

GI 360 NICHE-2 ipilimumab/nivolumab

Mage-tarm 020 FLV ved stråleterapi

Mage-tarm 021a GEMCAP Gemcitabin/kapecitabin

Mage-tarm 021b Gemcitabin/kapecitabin redusert

GI 021b Gemcitabin/kapecitabin redusert

GI 032 Karboplatin AUC2/paklitaksel

GI 035 Cifu infusor 120t uten stråleterapi

GI 055/132a/132b MiFu Fluorouracil/mitomycin ved strålebehandling

GI 238 EVIDENT Pembrolizumab -21

GI 287 CiFu-nivolumab infusor 80/4000 120 timer

GI 334 Ipilimumab 1 mg/kg/nivolumab 3 mg/kg

GI 335ab RASolute303  Gemcitabin/paklitakselalbumin/ daraxonrasib

GI 356 Studie IDeate-Esophageal01 Paklitaksel

GI 357 Studie IDeate-Esophageal01 Docetaksel

GI 358 Studie IDeate-Esophageal01 Irinotekan